Skip to main content
Clinical Trials/ITMCTR2000003007
ITMCTR2000003007
Not yet recruiting
未知

Traditional Chinese medicine cooperative therapy for patients with novel coronavirus pneumonia (COVID-19): a randomized controlled trial

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine0 sitesTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. Meet the diagnostic criteria of the New Coronavirus Pneumonia Diagnosis and Treatment Scheme, patients with pneumonia confirmed by new coronavirus infection;
  • 2\. Pneumonia Severity Index (PSI) grade is I \~ II;
  • 3\. Aged 18\-80 years;
  • 4\. Those who have signed the informed consent voluntarily.

Exclusion Criteria

  • 1\. People with allergies and allergies to experimental drugs;
  • 2\. Combined with other malignant tumors;
  • 3\. Patients with hematological diseases, coagulopathy and autoimmune diseases;
  • 4\. Combined with severe cardiovascular diseases, Patients with vascular disease, hematopoietic system disease, and neuropathy;
  • 5\. Participated in other clinical researchers 3 months before the trial.

Outcomes

Primary Outcomes

Not specified

Similar Trials